White House bats down speculation that Trump got access to Eli Lilly obesity drug for ‘compassionate use’

White House officials on Tuesday shot down a report speculating that President Trump gained access to the retatrutide weight-loss drug under the Food and Drug Administration’s “compassionate use program.” The retatrutide drug is manufactured by Eli Lilly and is not FDA approved.